What Is COMPASS Pathways Plc - American (CMPS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on COMPASS Pathways Plc - American at its current price of $13.31. The composite intrinsic value is estimated at $8.70 (-34.7% average return), with 6 models flagging overvaluation risk. Notably, Sentiment SOTP sees the most upside at +21.0% (fair value: $16.10), while Dynamic NAV is the most conservative at -90.9% ($1.21). The spread between these extremes — +111.9% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About CMPS?
9 of 13 models are currently active for CMPS. Of these, 3 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates CMPS's intrinsic value at $3.55, implying -73.3% downside from the current price. See which stocks rank higher →
How Does CMPS Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, CMPS ranks #403 by Quality of Company score. CirclFi's QOC score of 2.3/10 evaluates 32 fundamental signals. A score of 2.3 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Within the Pharmaceutical Preparations space, COMPASS Pathways Plc - American competes in an environment where patent cliff exposure often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is CMPS a Value Trap?
CirclFi's Value Trap algorithm assigns CMPS a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for COMPASS Pathways Plc - American. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, COMPASS Pathways Plc - American is rated at 2.3/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.
The gap between the most bullish and bearish model spans +111.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CMPS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CMPS's 9 active models, average confidence is 14%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad